Clinical Trial Update: Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial of recombinant antithrombin in heparin-resistant patients undergoing cardiac surgery was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombophilia Due to Acquired Antithrombin Iii Deficiency

Drugs mentioned

• Recombinant Antithrombin (recombinant human antithrombin III)

Snippet

Sponsor: Mayo Clinic | Conditions: Thrombophilia Due to Acquired Antithrombin III Deficiency | Phase 4 | Status: TERMINATED | Results posted: 2015-07-15